Health Canada has launched a public consultation regarding potential amendments to the Industrial Hemp Regulations, seeking feedback on a Notice of Intent published in the Canada Gazette on May […]
Health Canada has published Bulletin 10 which announced plans to introduce greater flexibility into the Natural Health Product (NHP) labelling regulations in response to implementation challenges raised by industry […]
On May 15, 2026, Health Canada published a Notice of Intent to introduce a Ministerial Order that will exempt certain low-risk, non-prescription drugs from traditional, extensive New Drug Submissions. […]
PRODUCT APPLICATIONS: Class I Applications: Currently meeting service standards. Class II Applications (meeting Workload Management eligibility criteria): There are approximately 900 prioritized files in Class II (this […]
The SCCS considers Acetophenone safe, when present as a constituent of natural complex substances that are used in cosmetic products, provided that its concentration does not exceed 100 ppm […]
On May 4th, the FDA posted an FDA Voices blog sharing how FDA is implementing the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) to positively impact public health. […]
On May 1st, CESI published its Spring Newsletter, which features 3 recently updated indicators that provide valuable insight into the state of Canada’s environment. Read on to learn more […]
The final version of the Watch List Approach was published April 28, 2026 on the CEPA Registry. The purpose of the Watch List is to identify substances that have […]
The Canadian Product Safety Pledge, launched Fall 2023 by Health Canada, was created to help protect people in Canada from health and safety risks associated with consumer products and […]
On April 24, 2026, NNHPD updated several health product monographs to include critical safety warnings, most notably regarding peripheral neuropathy risks with Vitamin B6 and increased bleeding risks for […]
